Back

Differences in heart failure with preserved ejection fraction diagnostic and therapeutic practices between physicians from europe and the middle east and north africa: an international survey

19 May 2025 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Diagnosis and prognosis of HFpEF Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Hamzah Alarfaj

King Faisal Specialist Hospital & Research Centre, Riyadh (Saudi Arabia)

3 More presentations in this session

Presentation thumbnail
Frailty and cardiovascular comorbidities as predictors of short-term outcomes in HFpEF and HFmrEF patients: a retrospective cohort analysis
Associate Professor A. Briasoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Peroxiredoxin-4 and beta-hydroxybutyrate after SGLT2 inhibitor treatment in heart failure with preserved ejection fraction
Miss A. Achten (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: the single centre experience
Assistant Professor M. Pandrc (Belgrade, RS)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and prognosis of HFpEF

The Event

Event poster

Heart Failure 2025

19 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Diagnostic and therapeutic practice for heart failure with preserved ejection fraction around the world: an international survey
thumbnail
Congress Presentation
HFpEF management comparison between HF-cardiologists, non-HF-cardiologists and other specialties: an international survey
thumbnail
Congress Presentation
Diagnostic and therapeutic practices for Heart Failure with preserved ejection fraction around the world: an international survey

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources